🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

JUMP_START - Optimization of Care for Young Cancer Patients with Gastrointestinal Tumors

Recruitingn/aAges 18 Years - anyAllUniversity Hospital Heidelberg
NCT06621277 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

JUMP\_START aims to assess the needs of individuals aged ≤ 50 years with gastrointestinal (GI) tumors and implement a tailored support and counseling program at the University Hospital Heidelberg and the National Center for Tumor Diseases (NCT). In phase 1A, 12-15 individuals aged ≤ 50 years with GI tumors will be interviewed via telephone using semi-structured interviews to obstain a detailed understanding of the life situation, the burdens, and the care situation within the structures of the NCT Heidelberg. In phase 1B, the care networks of young patients with GI tumors beyond the NCT, including the analysis of changes and important access routes/possible gatekeepers, will be explored using so-called ego-centered network analyses, in comparison with patients who received a GI tumor diagnosis after the age of 50. In response to the results of phase 1A and 1B, the care services for yo

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Individuals aged ≥ 18 and ≤ 50 years receiving treatment for a GI tumor at the Heidelberg University Hospital * Sufficient knowledge of the German language * Capable of providing informed consent * Additional recruitment for Phase 1B and Quality of Life assessments: Patients with GI tumor aged ≥ 51 years Exclusion Criteria: * Individuals with a GI tumor diagnosis after the age of 50 (except in Phase 1B and for Quality of Life assessments) * Individuals with a GI tumor diagnosis under the age of 18 * Lack of capacity to consent and/or absence of informed consent * Insufficient knowledge of the German language * Severe cognitive impairments
💊

What it tests

  • No intervention
  • Tailored counseling programs (Phase 2)
📍

Where

1 site
National Center for Tumor Diseases (NCT) Heidelberg
Heidelberg, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy